Searched for
LANCET STUDY ON COVID
Covid pandemic cut global life expectancy by nearly two years, says WHOThe amount of time the average person can expect to live in good health fell 1.5 years to 61.9 years in 2021 -- also the 2012 level, the st...- Diabetes drug may be the pill for long CovidTaking the diabetes drug metformin within three days of testing positive for Covid-19 may reduce the risk of developing long Covid by 40%, ...
- Simple nasal swab can provide early warning of stealthy viruses: Lancet studyPublic health officials typically look to a few sources for warning signs of emerging disease. They study emerging viruses in animals that ...
- High cholesterol and weight, reduced physical stamina may signal long COVID: Lancet study"These results have societal and public-health effects and can be used to guide strategies for broad interdisciplinary evaluation of COVID-...
- Covid-19 mRNA jabs safe during pregnancy: Lancet StudyThe study found 7.3% of pregnant women experienced health events requiring time off work or school or needing medical attention, such as he...
- Long Covid symptoms in children can last for 2 months, say expertsExperts stress there is no need to panic, but early treatment is crucial.
- Covid vaccine after infection give higher protection against illness, show 2 Lancet studiesAccording to the first study, conducted in Brazil, researchers found four vaccines provide additional protection against symptomatic reinfe...
- India had the highest excess deaths related to Coronavirus, says Lancet in new reportThe new study provides the first peer-reviewed estimates of excess deaths due to the pandemic globally and for 191 countries and territorie...
- Bharat Biotech’s Covaxin has 77.8% efficacy rate, presents no safety concerns: Lancet studyCovaxin “induces a robust antibody response" two weeks after two doses are given, it said. “Covaxin’s Phase 3 efficacy results have been pe...
- COVID-19 vaccines effective at reducing severe illness, hospitalisation: Lancet study"We are at a critical point in the pandemic as we see cases rising worldwide due to the Delta variant. Breakthrough infections are expected...
- Half of hospitalised Covid patients have persisting symptoms after a year: Lancet studyThe research on 1,276 patients from Wuhan, China, shows that around one in three people still experienced shortness of breath after 12 mont...
- British variant of COVID-19 not as severe as feared, according to The LancetThe strain, known as B.1.1.7, was identified in Britain late last year and has become the most common strain in the United States, accordin...
- One in 15 Indians Covid-19 infected by August: Lancet studyThe report, which was released in India last year in a non-peer reviewed journal, had the same findings on the spread of the disease. The f...
- Cases of reinfection could mean no possible immunity from virusSince we still dont know how long coronavirus antibodies last, it is difficult to create a vaccine which will fight off any second wave of ...
- 90-minute British DnaNudge COVID-19 test is accurate, Lancet study findsThe new test, based on the design of a DNA test developed by a professor at Imperial College London, received approval for clinical use by ...
- ET Explains: Why HCQ, Trump's Covid wonder drug, is in news againHCQ might not be as effective as previously told, a recently retracted Lancet study has found.
- Controversial Lancet study linking HCQ, deaths in Covid-19 treatment retractedThe authors of the research linking the malaria drug hydroxychloroquine and increased death risk during Covid-19 treatment have retracted t...
- An almost retracted study on hydroxychloroquine exposes perils of hasty trialsWHO last week stopped one arm of the Covid-19 Solidarity trial of HCQ, only to resume it again this week. Its decision to stop the trial wa...
- Lancet issues 'expression of concern' after scientists question validity of HCQ study"We are issuing an Expression of Concern to alert readers to the fact that serious scientific questions have been brought to our attention....
- Mixed opinion by Indian experts on WHO's temporary pause on hydroxychloroquine trialWhile some experts feel that after the WHO decisions, country's medical centres will have to take HCQ and chloroquine our of the treatment ...
Load More
